Panel Workshop Details
Profiting from the Next Wave in Tech & Biotech*
Disruptive innovations constantly change the way we live our lives, whether it's the cell phones changing the way we bank or buy goods and services or personalized therapies that can turn off diseases at their genetic source. And these innovations present opportunities for investors.
A pioneer in the development of stock-rating systems and screening software, Jon Markman is a co-inventor of two Microsoft patents, author of several best-selling books, and editor of Tech Trend Trader.
John McCamanthas spent 25 years on the front lines of biotechnology investing as an equities analyst for the American Healthcare Fund and lead fundraiser in a venture capital fund. He won MoneyShow.com's 2017 Top Pros' Top Picks Award for his stock pick with an eye-popping overall 519% return.
In this Master Class, you will hear from two towering tech and biotech experts who will identify several of the disruptive innovations taking place today and how technologies like AI, robotics, 3D printing for organ transplants, CRISPR and self-driving vehicles are creating amazing new investment opportunities.
$109 per person if purchased by April 22; $139 per person if purchased after April 22. Includes refreshments.
Please call for more information or to purchase tickets at 800-970-4355.